INMATION -6 TABLET

Actobacillus acidophilus LA-5 (500 Million CFU), Lactobacillus rhamnosus GG ATCC 53103 (LGG) (1.5 Billion CFU), Lactobacillus casei DN-114 001 (500 Million CFU), Lactobacillus plantarum 299V (300 Million CFU), Lactobacillus delbrueckii subsp. bulgaricus LBB-1 (200 Million CFU), Bifidobacterium longum BB-536 (400 Million CFU), Bifidobacterium infantis Bb-02 (400 Million CFU), Bifidobacterium breve Bb-03 (300 Million CFU), Streptococcus thermophilus TH-4 (200 Million CFU), Saccharomyces boulardii CNCM I-745 (250 Million CFU), Fructo-Oligosaccharides (FOS) (885 mg), and Elemental Zinc (as Zinc Gluconate) (10 mg).

Advanced Multi-Strain Probiotic + Prebiotic with Zinc

• 10 Clinically Studied Probiotic Strains: Delivers 4.9 Billion CFU per serving of well-researched strains including acidophilusLA-5, L. rhamnosus GG (LGG), L. casei DN-114 001, L. plantarum 299V, B. longum BB-536, B. infantis Bb-02, and S. boulardii CNCM I-745 for comprehensive gut microbiome support.
• Digestive & Immune Health: Supports regular bowel movements, reduces duration of common infectious diseases, and strengthens intestinal barrier function—particularly beneficial for children, adults, and elderly populations.
• Pediatric & Maternal Support: Includes infant-specific strains ( infantis, B. breve) shown to reduce eczema, atopic dermatitis, and functional abdominal pain in children; ideal for postpartum mothers and pediatric care.
• Prebiotic + Mineral Synergy: Enhanced with 885 mg Fructo-Oligosaccharides (FOS) to nourish beneficial bacteria and 10 mg elemental zinc (as zinc gluconate) for immune modulation and gut mucosal integrity.
• Multi-Target Formulation: Addresses constipation, diarrhea, IBS symptoms, antibiotic-associated digestive upset, respiratory illness duration, and allergic response modulation through strain-specific mechanisms.
• Pharmaceutical-Grade Quality: Each strain is identity-verified (ATCC, CNCM, DN designations) with documented safety profiles and over 260+ clinical studies supporting efficacy across gastrointestinal, immunological, and infectious health endpoints.

( Lactobacillus Rhamnosus GG (ATCC 53103) 6 billion spores) Mouth-Melt Granules

• World’s Most Researched Probiotic Strain: Delivers 6 billion CFU of rhamnosusGG (ATCC 53103), backed by 1,000+ scientific publications and 300+ clinical trials demonstrating safety and efficacy across gastrointestinal, immune, and oral health endpoints
• Pediatric Diarrhea Management: High-quality randomized trials and meta-analyses show LGG reduces duration of acute infectious diarrhea in children by approximately 24–48 hours when initiated early, particularly effective against rotavirus gastroenteritis.
• Antibiotic-Associated Diarrhea Prevention: Cuts risk of antibiotic-associated diarrhea from ~22% to ~12% (RR 0.49), with significant protective effects in children (RR 0.48) and hospitalized patients receiving antibiotics or chemotherapy.
• Gut Barrier & Microbiome Restoration: Strengthens non-immunological gut barrier, inhibits pathogen adhesion, and enhances mucosal immune response—supporting healthy stool consistency and reducing gastrointestinal disturbances from microbiome imbalance.
• Oral Health & Dental Integrity: Clinically demonstrated benefits in oral health, including inhibition of Streptococcus mutans, reduction of dental caries risk in children and young adults, and support for overall dental integrity.
• Convenient Mouth-Melt Delivery: Orodispersible granules dissolve rapidly in the mouth—no water required—ideal for children, travelers, and patients with swallowing difficulties while ensuring viable probiotic delivery to the GI tract.
• Additional Immune & Metabolic Support: May reduce infantile colic crying time in breastfed infants, improve childhood IBS abdominal pain (NNT 4), and show emerging evidence for allergy prevention, gestational diabetes risk reduction, and enhanced vaccine immune response.